LVT-001

BIOLOGICAL2 trials

Sponsors

Inserm, Centre Hospitalier Regional Universitaire De Tours, ANRS, Emerging Infectious Diseases

Conditions

HealthyHealthy volunteers

Phase 1

Randomized, controlled, multicenter Phase I/II study comparing the safety and immunogenicity of a booster dose of an intranasal COVID-19 vaccine expressing SARS-CoV-2 N/S recombinant proteins with a booster dose of COVID-19 mRNA vaccine in healthy adults

RecruitingCTIS2024-510589-17-00

Inserm, Centre Hospitalier Regional Universitaire De ToursHealthy volunteers

Start: 2025-05-09Target: 238Updated: 2025-09-05

Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy Adults

RecruitingNCT06821126

ANRS, Emerging Infectious DiseasesHealthy

Start: 2025-05-09End: 2028-03-31Target: 238Updated: 2025-12-18